| Announce Date | 02/04/2026 |
| EPS Normalized Actual | $-0.27954 (Miss by $-0.46354) |
| EPS GAAP Actual | $-0.27954 (Miss by $-0.46354) |
| Revenue Actual | $3.644B |
| Revenue Surprise | Beat by $3644M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.56 |
| EPS GAAP Estimate | $0.56 |
| Revenue Estimate | $3.9401B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 0 | INF | 0 | 0 | 1 |
| Sep 2029 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.28 | -1.03 | 3.644B | 4.09% | 8.05M |
| FQ3 2025 (Sep 2025) | 0.22 | 0.22 | 3.688B | 3.42% | 3688M |
| FQ2 2025 (Jun 2025) | 0.43 | 0.43 | 3.741B | 0.67% | 3741M |
| FQ1 2025 (Mar 2025) | -3.99 | -3.99 | 3.611B | -3.85% | 3611M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 3.495B | -4.72% | 3495M |
| FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 3.562B | 100% | 3562M |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 3.716B | -9.12% | 3716M |
| FQ1 2024 (Mar 2024) | -0.77 | -0.77 | 3.75B | -4.32% | 3750M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.56
Consensus Revenue Estimates
3.9401B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 1.1 | -- | 1.06247 | 1.14602 | 6 |
| FQ1 2028 (Mar 2028) | 1 | -- | 0.96589 | 1.04184 | 3 |
| FQ4 2027 (Dec 2027) | 0.69 | -- | 0.66646 | 0.71887 | 2 |
| FQ2 2027 (Jun 2027) | 1.06 | -- | 1.03563 | 1.09264 | 1 |
| FQ1 2027 (Mar 2027) | 0.77 | -- | 0.7523 | 0.79371 | 1 |
| FQ4 2026 (Oct 2026) | 1.38 | 120.29 | 1.36649 | 1.39247 | 3 |
| FQ3 2026 (Jul 2026) | 1.42 | 84.51 | 1.4061 | 1.43283 | 3 |
| FQ2 2026 (Jun 2026) | 1.42 | 69.72 | 1.37569 | 1.44639 | 3 |
| FQ1 2026 (Mar 2026) | 0.56 | 812.5 | 0.54253 | 0.57041 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Jun 2028) | 3.92B | -- | 3.82B | 4.05B | 2 |
| FQ1 2028 (Mar 2028) | 3.87B | -- | 3.77B | 4B | 2 |
| FQ4 2027 (Dec 2027) | 3.8B | -- | 3.7B | 3.92B | 3 |
| FQ2 2027 (Jun 2027) | 3.68B | -- | 3.62B | 3.77B | 2 |
| FQ1 2027 (Mar 2027) | 3.61B | -- | 3.54B | 3.69B | 2 |
| FQ4 2026 (Oct 2026) | 4.14B | 12.02 | 4.11B | 4.17B | 2 |
| FQ3 2026 (Jul 2026) | 4.23B | 12.91 | 4.2B | 4.26B | 2 |
| FQ2 2026 (Jun 2026) | 4.28B | 12.53 | 4.17B | 4.34B | 2 |
| FQ1 2026 (Mar 2026) | 3.94B | 8.35 | 3.85B | 4B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.75 | -0.28 | -1.03 | 367.86% |
| FQ3 2025 (Sep 2025) | 0.22 | 0.22 | 100% | |
| FQ2 2025 (Jun 2025) | 0.43 | 0.43 | 100% | |
| FQ1 2025 (Mar 2025) | -3.99 | -3.99 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 100% | |
| FQ2 2024 (Jun 2024) | -0.12 | -0.12 | 100% | |
| FQ1 2024 (Mar 2024) | -0.77 | -0.77 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $3.64B | $3.64B | $8.05M | 0.22% |
| FQ3 2025 (Sep 2025) | $0B | $3.69B | $3688M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $3.74B | $3741M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $3.61B | $3611M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.5B | $3495M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.56B | $3562M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.72B | $3716M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $3.75B | $3750M | 100% |